What happens when you take vitamin D3 with vitamin K2?
Vitamin D3 (cholecalciferol) and vitamin K2 (most commonly menaquinone-7, MK-7) operate on adjacent stages of calcium handling. After conversion to its active form 1,25-dihydroxyvitamin D, vitamin D3 increases dietary calcium absorption in the intestine and increases the production of two key proteins: osteocalcin in bone cells and matrix Gla protein (MGP) in arterial walls. Both proteins are made in an inactive form. Vitamin K2 carboxylates them, switching them on. Active osteocalcin binds calcium into bone, and active MGP keeps calcium out of arterial walls.
Without enough K2, vitamin D3 still raises blood calcium but the carrier proteins it induces remain inactive. The calcium then has fewer guard rails directing it to bone and away from soft tissue. With both vitamins adequate, the system works as designed.
Why is this important?
The pairing is the foundation of modern bone and cardiovascular nutrition. Vitamin D3 supplementation has become routine for adults with low blood 25-hydroxyvitamin D, but vitamin D alone does not direct the calcium it mobilizes. Vitamin K2 closes that loop.
Clinical evidence supports the pairing for bone outcomes. A three-year randomized trial in postmenopausal women with osteopenia using 180 mcg per day of MK-7 showed improved bone strength and microarchitecture. The INTRICATE study, registered in PubMed Central, uses Na[18F]F PET/MRI to assess whether combined MK-7 and vitamin D3 reduces arterial micro-calcification in carotid artery disease. Observational data from the Rotterdam Study link higher K2 intake with lower coronary calcification and reduced cardiovascular mortality.
The two vitamins also share absorption logistics: both are fat-soluble, both enter mixed micelles, and both are best absorbed with a meal that contains some fat. They are conveniently paired in a single softgel and do not compete for absorption or transport.
What should you do?
Take D3 and K2 together with a fat-containing meal. Common supplemental ratios pair 1,000-5,000 IU of D3 with 90-180 mcg of MK-7. If you are correcting deficiency with high-dose D3 (50,000 IU weekly is a common prescription regimen), pair it with daily K2 to ensure the calcium it mobilizes is directed to bone rather than left to deposit in arteries.
Stay within safety limits. The tolerable upper intake level for vitamin D in most adults is 4,000 IU per day from supplements unless higher doses are clinically indicated. Vitamin K2 has no established upper limit and is well tolerated at supplemental doses up to several hundred micrograms daily in healthy adults.
Important interaction: warfarin (Coumadin) and other vitamin K antagonists work by blocking vitamin K recycling. Vitamin K2 supplementation reduces warfarin's effect and can destabilize INR. If you take warfarin, do not start or change vitamin K2 without consulting your prescriber.
Which specific products are affected?
D3 plus K2 combination softgels are now one of the most common bone- and cardiovascular-support products. Typical formulations supply 1,000-5,000 IU of D3 and 45-180 mcg of MK-7 per softgel. The combination is also added to many bone-support stacks alongside calcium, magnesium, and boron.
The MK-7 form is preferred for once-daily dosing because of its long half-life (around 72 hours), which results in steady tissue concentrations. MK-4 has a much shorter half-life and is typically dosed two or three times per day at higher amounts, often as 15 mg three times daily in research settings. For most consumers, MK-7 at 90-180 mcg per day paired with D3 is the practical choice.
The bottom line
Vitamin D3 mobilizes calcium, and vitamin K2 directs it to bone instead of arteries. Take them together with a fat-containing meal, typically 1,000-5,000 IU D3 with 90-180 mcg MK-7 daily. Do not start vitamin K2 if you take warfarin without medical supervision.